medigraphic.com
Colegio de Medicina Interna de México.

2016, Number 2

<< Back Next >>

Med Int Mex 2016; 32 (2)

Human influenza virus as example of emergent disease in Mexico

Gutiérrez-Salinas J, Mondragón-Terán P, García-Ortíz L, Hernández-Rodríguez S, Romero-Domínguez E, Ramírez-García S, Núñez-Ramos NR

Language: Spanish
References: 40
Page: 213-224
PDF size: 734.54 Kb.


ABSTRACT

The influenza pandemic caused by the new H1N1 virus affected all the continents. In a globalized world, with many social inequities and evident climate changes, influenza viruses are a permanent risk for mankind. Infectious diseases remain among the leading causes of death and disability worldwide. Studies of these emerging infections reveal the evolutionary properties of pathogenic microorganisms and the dynamic relationships between microorganisms, their hosts and the environment. During a pandemic, a rapid response relies on the capacity for early warning and diagnosis based on effective epidemiological surveillance. From a public health standpoint, most vulnerable areas for the new influenza pandemics include developing countries, particularly the poorest ones, so that the greatest effort must be made for helping these areas.


REFERENCES

  1. Osterholm MT. Preparing for the next pandemic. N Engl J Med 2005;352:1839-1842.

  2. Taubenberger JK, Morens D. 1918 influenza: The mother of all pandemics. Emerg Infect Dis 2006;12:15-22.

  3. Kilbourne ED. Influenza pandemic of the 20th Century. Emerg Infect Dis 2006;12:9-14.

  4. Swayne DE. Avian influenza. In: Foreign animal diseases. Boca Raton, FL: United States Animal Health Association, 2008;137-146.

  5. Horimoto T, Kawaoka Y. Influenza: lessons from past pandemic, warnings from current incidents. Nature Rev Microbiol 2005;3:591-600.

  6. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992;56:152-179.

  7. Reid AH, Taubenberger JK, Fanning TG. Evidence of an absence: the genetic origins of the 1918 pandemic influenza virus. Nature Rev Microbiol 2004;2:909-914.

  8. Lade KS, Sawant SD, Singh MC. Review on influenza with special emphasis on swine flu. Int J Curr Pharm Res 2011;3:97-107.

  9. Medina RA, García-Sastre A. Influenza A viruses: new research developments. Nature Rev Microbiol 2011;9:590- 603.

  10. Watanabe T, Watanabe S, Kawaoka Y. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 2010;7:427-439.

  11. Mehle A, Doudna JA Adaptive strategies of the influenza virus polymerase for replication in humans. Proc Natl Acad Sci USA 2009;106:21312-21316.

  12. Wan H, Perez DR. Quail carry sialic acid receptors compatible with binding of avian and human influenza viruses. Virology 2006;346:278-286.

  13. Russell RJ, Stevens DJ, Haire LF, Gamblin SJ, Skehel JJ. Avian and human receptor binding by hemagglutinins of influenza A viruses. Glycoconj J 2006;23:85-92.

  14. Writing Committee of the Second World Health Organization consultation on clinical aspects of human infection with avian influenza A (H5N1) virus. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008;358:261-273.

  15. Secretaría de Salud, Subsecretaría de Prevención y Promoción de la Salud, Instituto de Diagnóstico y Referencia Epidemiológicos. Lineamientos para la vigilancia epidemiológica de influenza por laboratorio. Influenza-RNLSP/ InDRE Version Num. 01, 2013;1-152.

  16. Centers for Disease Control and Prevention (CDC). Outbreak of swine-origin influenza A (H1N1) virus infection- Mexico, March-April, 2009. MMWR Morb Mortal Wkly Rep 2009;58:467-470.

  17. Narain JP, Bhatia R. Influenza A (H1N1): Responding to a pandemic threat. Indian J Med Res 2009;129:465-467.

  18. Narain JP, Kumar R, Bhatia R. Pandemic (H1N1) 2009: epidemiological, clinical and prevention aspects. Natl Med J India 2009;22:242-247.

  19. Garten RJ, Davis CT, Russell CA, Shu B, et al. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 2009;325:197-201.

  20. Goñi-Mazzitelli N. Variabilidad genética y evolución molecular del virus de la influenza A en Uruguay. Tesis doctoral. Universidad de la República, Pedeciba Biología, Opción Microbiología, 2011;9-83.

  21. Smith GJ. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009;459:1122-1125.

  22. Ito T, et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 1998;72:7367-7373.

  23. Shinya K, et al. Avian flu: influenza virus receptors in the human airway. Nature 2006;440:435-436.

  24. Soundararajan V, et al. Extrapolating from sequence– the 2009 H1N1 ‘swine’ influenza virus. Nat Biotechnol 2009;27:510-513.

  25. Chen LM, et al. Receptor specificity of subtype H1 influenza A viruses isolated from swine and humans in the United States. Virology 2011;412:401-410.

  26. Childs RA, et al. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotechnol 2009;27:797-799.

  27. Russell RJ, Stevens DJ, Haire LF, Gamblin SJ, Skehel JJ. Avian and human receptor binding by hemagglutinins of influenza A viruses. Glycoconj J 2006;23:85-92.

  28. Tellier R. Review of aerosol transmission of influenza A virus. Emerg Infect Dis 2006;12:1657-1662.

  29. Nelson MI, Holmes EC. The evolution of epidemic influenza. Nature Rev Genet 2007;8:196-205.

  30. Talledo M, Zumaeta K. Los virus influenza y la nueva pandemia A/H1N1. Rev Peru Biol 2009;16:227-238.

  31. Daszak P, Cunningham AA. Anthropogenic change, biodiversity loss, and a new agenda for emerging diseases. J Parasitol 2003;89:37-41.

  32. Brown, C. Emerging zoonoses and pathogens of public health significance–an overview. Rev Sci Tech 2004;23:435- 442.

  33. Stramer SL, Hollinger FB, Katz ML, Kleinman S, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009;49:1-29.

  34. Yale G. Bhanurekha V, Ganesan PI. Anthropogenic factors responsible for emerging and re-emerging infectious diseases. Current Sci 2013;105:940-946.

  35. Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis 1995;1:7-15.

  36. Morens DM, Folkers GK, Fauci AS. Emerging infections: a perpetual challenge. Lancet Infect Dis 2008;8:710-719.

  37. WHO. Pandemic (H1N1) 2009-update. Disponible en: http://www.who.int/csr/don/2009.

  38. Carrada Bravo T. Avances recientes en el diagnóstico, epidemiología y prevención de la influenza. Revisión crítica. Rev Mex Patol Clin 2010;57:4-53.

  39. Osores FP, Gómez JB, Suárez LO, Cabezas CS, et al. Un nuevo virus A/H1N1, una nueva pandemia: influenza un riesgo permanente para una humanidad globalizada. Acta Med Per 2009;26:97-130.

  40. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009;459:931-939.




2020     |     www.medigraphic.com